A randomized study comparing interferon (IFN alpha) plus low-dose cytarabine and interferon plus hydroxyurea (HU) in early chronic-phase chronic myeloid leukemia (CML).

T Kühr, S Burgstaller, U Apfelbeck, W Linkesch, H Seewann, M Fridrik, G Michlmayr, O Krieger, D Lutz, W Lin, J Pont, L Köck, K Abbrederis, C Baldinger, R Buder, D Geissler, H Hausmaninger, A Lang, A Zabernigg, C DubaW Hilbe, W Eisterer, M Fiegl, Richard Greil, G Gastl, J Thaler

Research output: Contribution to journalOriginal Article (Journal)peer-review

16 Citations (Web of Science)
Original languageEnglish
Pages (from-to)405-411
JournalLEUKEMIA RESEARCH
Volume27
Issue number5
Publication statusPublished - 2003

Keywords

  • CHRONIC MYELOGENOUS LEUKEMIA
  • CYTOGENETIC RESPONSE
  • BUSULFAN
  • CHEMOTHERAPY
  • SURVIVAL
  • THERAPY
  • ALFA-2A
  • TRIAL

Cite this